These results, which were consistent with those obtained in vitro, indicate that artemisinin attenuated ischemic stroke-induced apoptosis through activation of the ERK1/2/CREB/BCL-2 signaling pathway. The gene discussed is MAPK3; the disease is ischemic stroke.